These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3250668)

  • 1. Did manic-depressive patients who committed suicide receive prophylactic or continuation treatment at the time?
    Schou M; Weeke A
    Br J Psychiatry; 1988 Sep; 153():324-7. PubMed ID: 3250668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relative prophylactic efficacy of lithium against manic and depressive recurrences in bipolar patients.
    Rybakowski J; Chłopocka-Woźniak M; Kapelski Z; Strzyzewski W
    Int Pharmacopsychiatry; 1980; 15(2):86-90. PubMed ID: 7440098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium therapy and prophylaxis in unipolar manic-depressive illness.
    Tudorache B; Micloş R; Sârbulescu A; Tudor S; Cânciu E
    Neurol Psychiatr (Bucur); 1988; 26(4):271-9. PubMed ID: 2905521
    [No Abstract]   [Full Text] [Related]  

  • 4. Has the time come to abandon prophylactic lithium treatment? A review for clinicians.
    Schou M
    Pharmacopsychiatry; 1998 Nov; 31(6):210-5. PubMed ID: 9930634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bupropion's prophylactic efficacy in bipolar affective illness.
    Shopsin B
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):163-9. PubMed ID: 6406450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium and relapse prevention in manic-depressive illness.
    Schou M
    Psychosomatics; 1983 Jun; 24(6):533-5, 537, 540-1. PubMed ID: 6136064
    [No Abstract]   [Full Text] [Related]  

  • 8. Lithium and suicide prevention in bipolar disorder.
    Benard V; Vaiva G; Masson M; Geoffroy PA
    Encephale; 2016 Jun; 42(3):234-41. PubMed ID: 27000268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bipolar disorders.
    McIntyre RS; Berk M; Brietzke E; Goldstein BI; López-Jaramillo C; Kessing LV; Malhi GS; Nierenberg AA; Rosenblat JD; Majeed A; Vieta E; Vinberg M; Young AH; Mansur RB
    Lancet; 2020 Dec; 396(10265):1841-1856. PubMed ID: 33278937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
    Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
    Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years' follow-up.
    Angst J; Angst F; Gerber-Werder R; Gamma A
    Arch Suicide Res; 2005; 9(3):279-300. PubMed ID: 16020171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction: managing bipolar depression.
    Bowden CL
    J Clin Psychiatry; 2004; 65 Suppl 10():3-4. PubMed ID: 15242325
    [No Abstract]   [Full Text] [Related]  

  • 13. Poor prophylactic lithium response due to antidepressants.
    Reginaldi D; Tondo L; Floris G; Pignatelli A; Kukopulos A
    Int Pharmacopsychiatry; 1981; 16(2):124-8. PubMed ID: 7333789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Issues in the treatment of bipolar disorder.
    Kasper S
    Eur Neuropsychopharmacol; 2003 Aug; 13 Suppl 2():S37-42. PubMed ID: 12957718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review.
    Altshuler L; Kiriakos L; Calcagno J; Goodman R; Gitlin M; Frye M; Mintz J
    J Clin Psychiatry; 2001 Aug; 62(8):612-6. PubMed ID: 11561933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.
    Ketter TA; Houston JP; Adams DH; Risser RC; Meyers AL; Williamson DJ; Tohen M
    J Clin Psychiatry; 2006 Jan; 67(1):95-101. PubMed ID: 16426094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suicide risk in placebo-controlled trials of treatment for acute manic episode and prevention of manic-depressive episode.
    Storosum JG; Wohlfarth T; Gispen-de Wied CC; Linszen DH; Gersons BP; van Zwieten BJ; van den Brink W
    Am J Psychiatry; 2005 Apr; 162(4):799-802. PubMed ID: 15800158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacological suicide prevention under special consideration of lithium salts].
    Müller-Oerlinghausen B
    Psychiatr Prax; 2007 Sep; 34 Suppl 3():S292-5. PubMed ID: 17786886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic efficacy of carbamazepine in manic-depressive illness.
    Post RM; Uhde TW; Ballenger JC; Squillace KM
    Am J Psychiatry; 1983 Dec; 140(12):1602-4. PubMed ID: 6139957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of pharmacotherapy on suicide rates in bipolar patients.
    Rihmer Z; Gonda X
    CNS Neurosci Ther; 2012 Mar; 18(3):238-42. PubMed ID: 22070662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.